JAMA Network

Interview with Trisha M. Wise-Draper, MD, PhD author of Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial. Hosted by Paul C. Bryson, MD MBA. Related Content: Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma

Interview with Maxine Germes, MD and Maxime K. Collard, MD, PhD authors of Oncologic Risk of Missed Appendiceal Tumors in Acute Appendicitis. Hosted by Jamie Coleman, MD. Related Content: Oncologic Risk of Missed Appendiceal Tumors in Acute Appendicitis Oncologic Implications of Nonoperative Appendicitis Treatment

Interview with T. Y. Alvin Liu, MD, author of Prevalence and Health Care Disparities of Retinal Conditions: A Meta-Analysis. Hosted by Neil Bressler, MD. Related Content: Prevalence and Health Care Disparities of Retinal Conditions

Interview with Rashmi Sarkar, MD, author of A Pigment-Informed Dermatology Framework—Reimagining “Skin of Color”. Hosted by Adewole S. Adamson, MD, MPP. Related Content: A Pigment-Informed Dermatology Framework—Reimagining “Skin of Color”

Interview with Balázs Szigeti, PhD, author of Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content: Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions

Hannes Vietzen, principal investigator at the Center of Virology in Vienna studying Epstein-Barr virus links to multiple sclerosis. He discusses why EBV is tied to MS and how specific EBV antibodies may help differentiate MS from other neuroinflammatory disorders. The conversation covers study design, longitudinal antibody patterns, and peptide-focused next steps.

L. Ebony Boulware, dean and physician–researcher focused on eliminating race-based medicine in kidney care. Rohan Khazanchi, resident and researcher who studied wait time changes for Black transplant candidates. They discuss removing race from eGFR equations, OPTN policy to recalculate wait time, measured impacts on transplant timing and rates, and other clinical algorithms needing race-free reform.

Paula Anne Newman-Casey, associate professor of ophthalmology at the University of Michigan and lead author of the SEE trial, discusses a personalized glaucoma coaching program. She talks about the scope of medication nonadherence. She explains how the SEE program was designed, its format of in-person sessions and coach calls, trial results showing improved adherence, and considerations for wider implementation.

Interview with Cody Lendon Mullens, MD, MPH, MS, and Dana A. Telem, MD, MPH, authors of Contemporary Outcomes of Cholecystectomy. Hosted by Jamie Coleman, MD. Related Content: Contemporary Outcomes of Cholecystectomy From Safer Cholecystectomy to Smarter Bile Duct Management

Interview with Christian S. Hendershot, PhD, and Klara R. Klein, MD, PhD, authors of Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder Semaglutide Shows Promise in Reducing Alcohol Cravings